Epilepsy device developer NeuroSigma has withdrawn its $50M IPO plans
The Los Angeles-based company developing its drug-resistant epilepsy system has officially backed out of its IPO plans.
Monarch eTNS system
The Los Angeles-based company developing its drug-resistant epilepsy system has officially backed out of its IPO plans.